Department of Microbiology and Immunology, Kilimanjaro Christian Medical University College, Moshi, Kilimanjaro, Tanzania, United Republic of
Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.
BMJ Open. 2024 Oct 26;14(10):e085580. doi: 10.1136/bmjopen-2024-085580.
The objectives are to determine the prevalence of urinary tract infection (UTI) and associated factors among patients diagnosed with benign prostatic hyperplasia and prostate cancer.
Hospital-based cross-sectional study.
Urology clinic and urology ward at Muhimbili National Hospital, which is the main tertiary hospital in Tanzania's largest city.
Patients with benign prostate hyperplasia and prostate cancer presenting with genitourinary symptoms.
The primary outcome was the occurrence of UTI and factors associated with UTI in patients with benign prostatic hyperplasia and prostate cancer.
402 participants were enrolled, with a median age of 68 years and IQR of 61-75 years. The proportion of UTI was 46.5% (95% CI 41.56% to 51.53%). UTI was more prevalent among inpatients, patients with indwelling urinary catheters, patients with prostate size>80 cm and those with residual urine volume of >100 mL. In multivariate analysis, age>60 years (adjusted OR (aOR)=2.0, 95% CI 1.13 to 3.55, p=0.018), post-void residual urine volume>100 mL (aOR 1.32, 95% CI 0.67 to 2.59 p=0.001), patient with incomplete bladder emptying (aOR=2.57, 95% CI 1.44 to 4.59, p=0.001) and prolonged catheter duration (aOR=1.24, 95% CI 1.11 to 1.38, p=0.005) were significantly associated with UTI.
Almost half of the patients with an enlarged prostate and genitourinary symptoms had a laboratory-confirmed UTI. The risk of UTI increases with age, incomplete bladder emptying and increased duration of catheterisation. A 1-day increase in the duration of catheterisation increased the risk of UTI by 24%.
本研究旨在确定诊断为良性前列腺增生和前列腺癌患者中尿路感染(UTI)的患病率及其相关因素。
基于医院的横断面研究。
坦桑尼亚最大城市的主要三级医院穆希比利国家医院的泌尿科诊所和泌尿科病房。
出现下尿路症状的良性前列腺增生和前列腺癌患者。
主要结局为良性前列腺增生和前列腺癌患者中 UTI 的发生及与 UTI 相关的因素。
共纳入 402 名参与者,中位年龄为 68 岁,IQR 为 61-75 岁。UTI 的比例为 46.5%(95%CI 41.56%至 51.53%)。住院患者、留置导尿管患者、前列腺体积>80cm 患者和残余尿量>100ml 患者中 UTI 的患病率更高。多变量分析显示,年龄>60 岁(调整后的 OR(aOR)=2.0,95%CI 1.13 至 3.55,p=0.018)、残余尿量>100ml(aOR 1.32,95%CI 0.67 至 2.59,p=0.001)、不完全排空膀胱(aOR=2.57,95%CI 1.44 至 4.59,p=0.001)和导尿管留置时间延长(aOR=1.24,95%CI 1.11 至 1.38,p=0.005)与 UTI 显著相关。
近一半出现下尿路症状的前列腺增大患者存在实验室确诊的 UTI。UTI 的风险随着年龄的增长、膀胱排空不完全和导尿管留置时间的延长而增加。导尿管留置时间每增加 1 天,UTI 的风险增加 24%。